Mitochondrial Functions and Oxidative Stress in ALS Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00331812|
Recruitment Status : Unknown
Verified January 2011 by University Hospital, Clermont-Ferrand.
Recruitment status was: Recruiting
First Posted : May 31, 2006
Last Update Posted : January 19, 2011
|Condition or disease||Intervention/treatment|
|Amyotrophic Lateral Sclerosis||Procedure: Mitochondrial functions and oxidative stress|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Study of Mitochondrial Functions and Oxidative Stress in ALS Patients.|
|Study Start Date :||February 2006|
|Estimated Study Completion Date :||February 2008|
- relationship between these abnormalities and the metabolic status (hypermetabolism or normometabolism).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00331812
|Contact: Corinne Bouteloup, Dr||(+33) 04 73 75 05 firstname.lastname@example.org|
|Clermont-Ferrand University Hospital||Recruiting|
|Clermont-Ferrand, Auvergne, France, 63000|
|Principal Investigator:||Corinne Bouteloup, Dr||University Hospital, Clermont-Ferrand|